Table 1.

Participant demographic and clinical characteristics

Participants	N=237
Gender
Male	122 (51.5%)
Female	115 (48.5%)
Practice setting
District general hospital	123 (51.9%)
Tertiary centre	41 (17.3%)
Teaching hospital	103 (43.5%)
Private practice	9 (3.8%)
Grade
Consultant gastroenterologist	109 (46%)
Registrar/fellow (gastroenterology)	35 (14.8%)
IBD nurse specialist (nurse practitioner)	93 (39.2%)
Age
25–34	40 (16.9%)
35–44	78 (32.9%)
45–54	93 (39.2%)
55–64	22 (9.3%)
>65	4 (1.7%)
Years (post gastroenterology certification) in practice
Still in training	30 (12.6%)
<1	9 (3.8%)
1–4	40 (16.9%)
5–9	50 (21.1%)
10–19	68 (28.7%)
>20	40 (16.9%)
Per cent of patients with IBD in individual practice
<10	2 (0.8%)
11–25	44 (18.6%)
26–50	51 (21.5%)
>50	140 (59.1%)
Patients with IBD treated per month (N)
5–10	10 (4.2%)
11–20	34 (14.3%)
20–30	30 (12.7%)
>30	163 (68.8%)
Patients treated with anti-TNF in a month
1–4	34 (14.3%)
5–10	59 (24.9%)
11–20	144 (60.8%)

IBD, inflammatory bowel disease.